To the Editor:

The authors read with interest the article about the performance of three risk stratifying scores in patients with upper gastrointestinal bleeding (UGIB) applied in a Korean population, by Choe *et al*.,[@b1-gnl-12-111] recently published in *Gut and Liver*.

UGIB is one of the most common emergencies for gastroenterologists, and, as previously discussed in the mentioned article, early risk stratification is important to determine priorities and define which patients benefit from early endoscopy and more aggressive clinical intervention. Although there are risk scores to predict clinical outcomes in UGIB, the most used being the Glasgow-Blatchford score (GBS), Rockall score (RS), and AIMS65 score (AIMS65), uncertainty still exists about the optimal score that could be uniformly applied in clinical practice. In addition, because most studies about risk scoring excluded patients with variceal bleeding, few data are available on the use of this scores in patients with variceal bleeding.

We recently conducted a retrospective single-center study which compared the performance of three scoring systems (GBS, RS, and AIMS65) in Portuguese patients. The consecutive patients admitted to our institution's emergency department with UGIB over a period of 12 months (between January 2016 and December 2016) were included. Both patients with variceal and nonvariceal bleeding were included. Two major endpoints were considered: (1) composite endpoint--need for any clinical intervention (transfusion, endoscopic therapy, surgery or radiological intervention) and (2) UGIB related mortality at 30 days after admission. The accuracy of each scoring system for the considered endpoints was calculated using the area under the receiver operating characteristic curve (AUROC), with 95% confidence interval. Statistical analysis was performed on MedCalc^®^ statistical software (Medcalc Software, Mariakerke, Belgium).

A total of 202 patients were included, the majority (75%) being male, with a mean age of 67 years. The mean time from admission to endoscopy was 15.8 hours. The main endoscopic findings were peptic ulcer disease (37%), variceal bleeding (24%) and erosive disease (16%). Six percent of patients had normal endoscopy. The overall rate of 30-day mortality directly related to the UGIB was 7%. The characteristics and the outcomes of the series of patients are described in [Table 1](#t1-gnl-12-111){ref-type="table"}. For the composite endpoint (need for clinical intervention), the AUROCs of GBS, RS, and AIMS65 were, respectively, 0.833, 0.781 and 0.636 in nonvariceal bleeding versus 0.630, 0.543 and 0.620 in variceal bleeding ([Figs 1](#f1-gnl-12-111){ref-type="fig"} and [2](#f2-gnl-12-111){ref-type="fig"}). For 30-day mortality, the AUROCs of RS, AIMS65 and GBS were, respectively, 0.864, 0.822 and 0.807 in nonvariceal bleeding and 0.783, 0.826 and 0.793 in variceal bleeding ([Figs 3](#f3-gnl-12-111){ref-type="fig"} and [4](#f4-gnl-12-111){ref-type="fig"}).

GBS was the only effective score to predict the need for clinical intervention, but in our population that was only true for patients with nonvariceal bleeding. Regarding mortality, the three scores showed a reasonable performance for both variceal and nonvariceal bleeding, but AIMS65 outperformed GBS.

As in the Korean study, GBS seems superior in its ability to predict need for clinical intervention in the nonvariceal bleeding group. Although we had a similar percentage of patients with variceal bleeding as the Korean study, we could not conclude the same in that specific group of patients. GBS seems the best score to predict need for clinical intervention in patients with nonvariceal bleeding, but we would not recommend its use in the variceal group in the Portuguese population.

As in the Korean population, AIMS65 does not seem good to predict clinical intervention in patients admitted with UGIB in the Portuguese population. However, it outperformed GBS and seems a good score to predict mortality both in the nonvariceal and variceal bleeding patients. In fact, AIMS65 was designed to determine predictors of mortality.[@b2-gnl-12-111] We should keep in mind that each score was developed to determine a specific, and sometimes different, outcome. Regarding RS, contrary to GBS and AIMS65, it requires endoscopic features, so it is not useful to stratify patients at admission.[@b3-gnl-12-111]

In conclusion, in the Portuguese population, GBS seems the best score that predicts need for clinical intervention, but only in patients with nonvariceal UGIB. Although the AIMS65 score is not optimal at predicting clinical intervention, it seems a good at predicting mortality, both in the nonvariceal and variceal UGIB Portuguese population. Although these scores systems are helpful to stratify UGIB patients, its application to different populations should be used with caution, since the causes of UGIB differ considerably among countries.[@b1-gnl-12-111] An ideal scoring system that is uniformly and universally appropriate in clinical practice is yet to be defined.
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###### 

Characteristics and Clinical Outcomes of the Study Population (n=202)

  Variable                                                      Value
  ------------------------------------------------------------- --------------
  Age, yr                                                       67 (31--94)
  Male sex                                                      151 (75)
  Comorbidities                                                 
   Heart failure                                                38 (19)
   Chronic liver disease                                        55 (27)
   Chronic kidney disease                                       20 (10)
   Metastatic malignancy                                        24 (12)
  Endoscopic findings                                           
   None                                                         12 (6)
   Erosive disease[\*](#tfn3-gnl-12-111){ref-type="table-fn"}   32 (16)
   Gastric or duodenal ulcer                                    75 (37)
   Variceal bleeding                                            49 (24)
   Malignancy of the upper GI tract                             14 (7)
   Dieulafoy                                                    6 (3)
   Mallory-Weiss tear                                           6 (3)
   Gastric/duodenal angiodysplasia                              8 (4)
  Mean time of hospital stay, day                               8.9 (0--32)
  Treatments                                                    
   Blood transfusion                                            93 (46)
   Endoscopic treatment                                         101 (50)
   Surgery                                                      12 (6)
  Outcome                                                       
   30-Day mortality                                             14 (7)
  Mean score                                                    
   Glasgow-Blatchford                                           10.1 (0--20)
   AIMS65                                                       1.5 (0--4)
   Rockall                                                      5.8 (0--11)

Data are presented as mean (range) or number (%).

GI, gastrointestinal.

Esophagitis, gastritis, and duodenitis.
